Fortitude Family Office’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.6K Sell
470
-23
-5% -$2.05K 0.01% 296
2026
Q1
$35.4K Buy
493
+195
+65% +$15K 0.01% 300
2025
Q4
$23.6K Buy
298
+76
+34% +$5.99K 0.01% 367
2025
Q3
$16.7K Buy
222
+21
+10% +$1.44K ﹤0.01% 432
2025
Q2
$13.9K Buy
+201
New +$13.2K ﹤0.01% 460
2024
Q4
Sell
-437
Closed -$27.5K 1311
2024
Q3
$27.5K Sell
437
-637
-59% -$37.2K 0.01% 348
2024
Q2
$63.4K Sell
1,074
-21
-2% -$1.31K 0.04% 147
2024
Q1
$87.3K Hold
1,095
0.06% 104
2023
Q4
$86.5K Buy
+1,095
New +$77.9K 0.06% 110

Other funds holding CVS

Fortitude Family Office's CVS Position: Q2 2026 in Review

Fortitude Family Office reduced its CVS Health (CVS) stake by 4.7% in Q2 2026, selling an estimated $2.05K and leaving 470 shares worth $48.6K. The position accounts for 0.01% of the portfolio, ranked #296.

Fortitude Family Office first reported a position in CVS in Q4 2023 and has held it in 9 quarters since. The position peaked at $87.3K in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Fortitude Family Office held 470 shares of CVS Health worth $48.6K as of Q2 2026.
  • Fortitude Family Office sold 23 CVS Health shares in Q2 2026, an estimated $2.05K.
  • CVS Health made up 0.01% of Fortitude Family Office's portfolio in Q2 2026, its #296 holding.
  • Fortitude Family Office first reported a position in CVS Health in Q4 2023 and has held it in 9 quarters since.
  • Fortitude Family Office's CVS Health position peaked at $87.3K in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.